Sands Capital Management LLC Acquires 35,849 Shares of Intuitive Surgical, Inc. $ISRG

Sands Capital Management LLC grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.7% in the fourth quarter, Holdings Channel.com reports. The firm owned 1,376,958 shares of the medical equipment provider’s stock after buying an additional 35,849 shares during the period. Intuitive Surgical comprises about 2.4% of Sands Capital Management LLC’s investment portfolio, making the stock its 17th biggest position. Sands Capital Management LLC’s holdings in Intuitive Surgical were worth $779,854,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Sargent Investment Group LLC bought a new position in Intuitive Surgical during the fourth quarter worth about $1,442,000. MML Investors Services LLC boosted its position in Intuitive Surgical by 8.6% during the fourth quarter. MML Investors Services LLC now owns 47,973 shares of the medical equipment provider’s stock worth $27,170,000 after purchasing an additional 3,789 shares during the period. Mariner LLC boosted its position in Intuitive Surgical by 31.7% during the fourth quarter. Mariner LLC now owns 132,129 shares of the medical equipment provider’s stock worth $74,858,000 after purchasing an additional 31,784 shares during the period. MayTech Global Investments LLC boosted its position in Intuitive Surgical by 2.2% during the fourth quarter. MayTech Global Investments LLC now owns 70,955 shares of the medical equipment provider’s stock worth $40,189,000 after purchasing an additional 1,548 shares during the period. Finally, Motiv8 Investments LLC bought a new position in Intuitive Surgical during the fourth quarter worth about $34,000. Institutional investors own 83.64% of the company’s stock.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analyst coverage remains broadly constructive, with brokerage sentiment still at a “Moderate Buy” and recent EPS estimate increases signaling confidence in Intuitive Surgical’s growth outlook.
• Positive Sentiment: Recent commentary highlights that the company’s scale, cost discipline, and adoption of the da Vinci 5 platform could help protect margins even if tariffs and input costs remain a concern.
• Neutral Sentiment: Investor attention has increased around ISRG, which can support trading activity, but this appears more like watchlist interest than a fresh business catalyst.
• Neutral Sentiment: BofA trimmed its price target slightly to $515 from $520, which still implies upside but signals a bit less optimism than before. Article: BofA adjusts price target on Intuitive Surgical to $515 from $520
• Neutral Sentiment: Two executives sold shares under pre-arranged 10b5-1 plans, including EVP Gary Loeb and EVP Mark Brosius. The sales were relatively small and routine, so they are unlikely to be a major fundamental concern.
• Negative Sentiment: One recent research note was notably bearish, with Deutsche Bank cutting its target to $366 and maintaining a sell rating, reinforcing concerns that valuation may still be too rich despite the company’s strong operating performance.
• Negative Sentiment: Seeking Alpha published a view calling Intuitive Surgical an “excellent business, unattractive stock,” reflecting ongoing investor caution around the valuation. Article: Intuitive Surgical: Excellent Business, Unattractive Stock

Wall Street Analysts Forecast Growth

ISRG has been the subject of a number of research reports. Mizuho set a $525.00 target price on shares of Intuitive Surgical and gave the stock a “neutral” rating in a research report on Monday, April 13th. Raymond James Financial cut their target price on shares of Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating for the company in a research report on Wednesday, April 22nd. Robert W. Baird increased their target price on shares of Intuitive Surgical from $575.00 to $610.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 22nd. Wall Street Zen upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday. Finally, JPMorgan Chase & Co. cut their target price on shares of Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Nineteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $571.28.

Intuitive Surgical Stock Performance

ISRG stock opened at $411.06 on Monday. The firm has a 50 day moving average of $442.88 and a 200-day moving average of $495.68. Intuitive Surgical, Inc. has a 12 month low of $396.68 and a 12 month high of $603.88. The firm has a market capitalization of $145.58 billion, a P/E ratio of 49.83, a price-to-earnings-growth ratio of 3.28 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The company had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. During the same period last year, the business earned $1.81 earnings per share. Intuitive Surgical’s revenue was up 23.0% compared to the same quarter last year. Sell-side analysts predict that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

Insider Activity

In other news, Director Amy L. Ladd sold 500 shares of the firm’s stock in a transaction that occurred on Tuesday, April 28th. The shares were sold at an average price of $473.46, for a total value of $236,730.00. Following the completion of the transaction, the director directly owned 239 shares in the company, valued at approximately $113,156.94. This trade represents a 67.66% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction that occurred on Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total transaction of $169,656.00. Following the completion of the sale, the executive vice president directly owned 5,720 shares in the company, valued at $2,426,080.80. This represents a 6.54% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 7,169 shares of company stock worth $3,059,135. 0.60% of the stock is owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.